Found 0 matching trials
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NAThe recent histo-prognostic molecular discoveries of the TCGA (The Cancer G...
Location
CHU Poitiers, PRC
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
N/AThis is a prospective observational registry for patients with invasive lob...
Location
University of California, San Diego
Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence
N/ATo evaluate the accuracy and effectiveness of a novel screening method base...
Location
Cancer Hospital Chinese Academy of Medical Sciences
Biological Analysis of MABs in NHL in a Translational Prospective Observational Study Within Italian Clinical Practice
N/AThis a prospective, multicenter, observational pharmacological translationa...
Location
Ematologia - Fondazione del Piemonte per l'Oncologia - IRCCS
PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study
N/AThis is a multi-centre, prospective, translational study investigating the ...
Location
Beaumont Hospital
Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)
PHASE2The phase II APPLE trial gives the opportunity to prospectively validate li...
Location
Institut Jules Bordet
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
N/ALung cancer is currently the world's largest malignant tumor for cancer-rel...
Location
Department of Oncology, The Second Xiangya Hospital, Central South University
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
N/AEarlier detection of disease recurrence will enable greater treatment optio...
Location
Washington University School of Medicine
The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study
N/AThe next-generation sequencing (NGS) based on liquid biopsy has been an eme...
Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer
PHASE2This study will utilize ctDNA methylation detection to evaluate patients wi...
Location
Fudan University Shanghai Cancer Center